Literature DB >> 27638939

Role of Metabolism in the Immunobiology of Regulatory T Cells.

Mario Galgani1, Veronica De Rosa2, Antonio La Cava3, Giuseppe Matarese4.   

Abstract

Intracellular metabolism is central to cell activity and function. CD4(+)CD25(+) regulatory T cells (Tregs) that express the transcription factor FOXP3 play a pivotal role in the maintenance of immune tolerance to self. Recent studies showed that the metabolism and function of Tregs are influenced significantly by local environmental conditions and the availability of certain metabolites. It also was reported that defined metabolic programs associate with Treg differentiation, expression of FOXP3, and phenotype stabilization. This article reviews how metabolism modulates FOXP3 expression and Treg function, what environmental factors are involved, and how metabolic manipulation could alter Treg frequency and function in physiopathologic conditions.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27638939      PMCID: PMC5027986          DOI: 10.4049/jimmunol.1600242

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  121 in total

1.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

2.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

4.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

5.  Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.

Authors:  Laura Negrotto; Mauricio F Farez; Jorge Correale
Journal:  JAMA Neurol       Date:  2016-05-01       Impact factor: 18.302

6.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

7.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

Review 8.  Transcriptional control of regulatory T cell development and function.

Authors:  Chong T Luo; Ming O Li
Journal:  Trends Immunol       Date:  2013-09-06       Impact factor: 16.687

9.  IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.

Authors:  Reiner K W Mailer; Anne-Laure Joly; Sang Liu; Szabolcs Elias; Jesper Tegner; John Andersson
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

10.  Meta-immunological profiling of children with type 1 diabetes identifies new biomarkers to monitor disease progression.

Authors:  Mario Galgani; Rosa Nugnes; Dario Bruzzese; Francesco Perna; Veronica De Rosa; Claudio Procaccini; Enza Mozzillo; Corrado M Cilio; Helena Elding Larsson; Ake Lernmark; Antonio La Cava; Adriana Franzese; Giuseppe Matarese
Journal:  Diabetes       Date:  2013-02-08       Impact factor: 9.461

View more
  43 in total

1.  Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.

Authors:  Angelika Schmidt; Francesco Marabita; Narsis A Kiani; Catharina C Gross; Henrik J Johansson; Szabolcs Éliás; Sini Rautio; Matilda Eriksson; Sunjay Jude Fernandes; Gilad Silberberg; Ubaid Ullah; Urvashi Bhatia; Harri Lähdesmäki; Janne Lehtiö; David Gomez-Cabrero; Heinz Wiendl; Riitta Lahesmaa; Jesper Tegnér
Journal:  BMC Biol       Date:  2018-05-07       Impact factor: 7.431

2.  Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation.

Authors:  Megan R Showalter; Benjamin Wancewicz; Oliver Fiehn; Joehleen A Archard; Shannon Clayton; Joseph Wagner; Peter Deng; Julian Halmai; Kyle D Fink; Gerhard Bauer; Brian Fury; Nicholas H Perotti; Michelle Apperson; Janelle Butters; Peter Belafsky; Gregory Farwell; Maggie Kuhn; Jan A Nolta; Johnathon D Anderson
Journal:  Biochem Biophys Res Commun       Date:  2019-03-26       Impact factor: 3.575

3.  Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade.

Authors:  Feng Wang; Qian Yin; Liang Chen; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-18       Impact factor: 11.205

Review 4.  Chair's Summary: Obesity and Associated Changes in Metabolism, Implications for Lung Diseases.

Authors:  Anne E Dixon; Benjamin T Suratt
Journal:  Ann Am Thorac Soc       Date:  2017-11

Review 5.  Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice.

Authors:  Kiley Bax; Paul J Isackson; Molly Moore; Julian L Ambrus
Journal:  Curr Rheumatol Rep       Date:  2020-02-14       Impact factor: 4.592

6.  IL2 is required for functional maturation of regulatory T cells.

Authors:  Phil Hyun Jeon; Kwon Ik Oh
Journal:  Anim Cells Syst (Seoul)       Date:  2016-12-30       Impact factor: 1.815

7.  Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity.

Authors:  Themis Alissafi; Lydia Kalafati; Maria Lazari; Anastasia Filia; Ismini Kloukina; Maria Manifava; Jong-Hyung Lim; Vasileia Ismini Alexaki; Nicholas T Ktistakis; Triantafyllos Doskas; George A Garinis; Triantafyllos Chavakis; Dimitrios T Boumpas; Panayotis Verginis
Journal:  Cell Metab       Date:  2020-07-31       Impact factor: 27.287

Review 8.  Beyond BMI: Obesity and Lung Disease.

Authors:  Ubong Peters; Benjamin T Suratt; Jason H T Bates; Anne E Dixon
Journal:  Chest       Date:  2017-07-17       Impact factor: 9.410

9.  Protein Prenylation Drives Discrete Signaling Programs for the Differentiation and Maintenance of Effector Treg Cells.

Authors:  Wei Su; Nicole M Chapman; Jun Wei; Hu Zeng; Yogesh Dhungana; Hao Shi; Jordy Saravia; Peipei Zhou; Lingyun Long; Sherri Rankin; Anil Kc; Peter Vogel; Hongbo Chi
Journal:  Cell Metab       Date:  2020-11-17       Impact factor: 27.287

Review 10.  Metabolic Reprogramming in Immune Response and Tissue Inflammation.

Authors:  Lizhe Sun (孙李哲); Xiaofeng Yang (杨晓峰); Zuyi Yuan (袁祖贻); Hong Wang (王虹)
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-07-23       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.